🔗 Permalink

Inventor profile of:

Patrick William Garibay

City:

Holte

Country:

Denmark

Published Applications:

Last publication date:

2023-07-27

Top Assignees for applications by Patrick William Garibay

The entities that hold a legal rights for patent applications filed by inventor Garibay Patrick William:

Novo Nordisk A/S 36 Bagsvaerd, Denmark
NOVO NORDISK HEALTHCARE A/G 4 Zurich, Switzerland
Novo Nordisk Health Care AG 2 Zurich, Switzerland
NOVO NORDISK A/S 2 Bagsvard, Denmark
NOVO NORDISK A/S 1 BEGSVAEND, Denmark

Recent patent applications by Garibay Patrick William

Patrick William Garibay from Holte, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-07-27

US20230233650A1

Human necessities

NOVEL FATTY ACID MODIFIED UROCORTIN 2 DERIVATIVES AND THE USES THEREOF

#2 | 2022-08-25

US20220265777A1

Human necessities

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#3 | 2020-12-31

US20200407409A1

Chemistry; metallurgy

EGF(A) ANALOGUES WITH FATTY ACID SUBSTITUENTS

#4 | 2020-04-23

US20200123215A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#5 | 2019-04-18

US20190112348A1

Chemistry; metallurgy

PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES

#6 | 2019-02-07

US20190038721A1

Human necessities

GLP-1 derivatives and uses thereof

#7 | 2019-01-17

US20190016768A1

Chemistry; metallurgy

EGF(A) analogues with fatty acid substituents

#8 | 2018-08-30

US20180244742A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#9 | 2017-05-25

US20170145069A1

Chemistry; metallurgy

GLP-1 derivatives

#10 | 2017-04-27

US20170114116A1

Chemistry; metallurgy

Double-acylated GLP-1 compounds

#11 | 2015-07-30

US20150210748A1

Chemistry; metallurgy

Protease stabilized acylated insulin analogues

#12 | 2015-07-30

US20150210747A1

Chemistry; metallurgy

Protease stabilized acylated insulin analogues

#13 | 2015-07-30

US20150210745A1

Chemistry; metallurgy

Double-Acylated GLP-1 Derivatives with a Linker

#14 | 2014-10-09

US20140303083A1

Chemistry; metallurgy

GLP-1 derivatives

#15 | 2014-06-26

US20140179899A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#16 | 2014-03-13

US20140073564A1

Chemistry; metallurgy

Protease stabilized, acylated insulin analogues

#17 | 2014-01-09

US20140011732A1

Chemistry; metallurgy

Peptides derivatized with A-B-C-D- and their therapeutical use

#18 | 2013-12-19

US20130338068A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives with a linker

#19 | 2013-10-31

US20130288960A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#20 | 2013-09-26

US20130252884A1

Chemistry; metallurgy

FGF21 ANALOGUES AND DERIVATIVES

#21 | 2013-07-25

US20130190232A1

Human necessities

N-terminal modified FGF21 compounds

#22 | 2013-02-28

US20130053311A1

Chemistry; metallurgy

GLP-1 analogues and derivatives

#23 | 2012-08-16

US20120208749A1

Human necessities

Insulin derivatives

#24 | 2012-02-09

US20120035104A1

Human necessities

Insulin derivatives

#25 | 2011-09-15

US20110223151A1

Human necessities

Conjugated proteins with prolonged in vivo efficacy

#26 | 2011-07-07

US20110166321A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#27 | 2011-05-05

US20110105720A1

Chemistry; metallurgy

Protease stabilized, acylated insulin analogues

#28 | 2011-04-28

US20110098440A1

Chemistry; metallurgy

Insulin analogues with an acyl and alkylene glycol moiety

#29 | 2011-04-07

US20110082079A1

Chemistry; metallurgy

Glucagon-Like Peptide-1 derivatives and their pharmaceutical use

#30 | 2010-12-16

US20100317057A1

Chemistry; metallurgy

Semi-recombinant preparation of GLP-1 analogues

#31 | 2010-11-18

US20100292133A1

Chemistry; metallurgy

TRUNCATED GLP-1 DERIVATIES AND THEIR THERAPEUTICAL USE

#32 | 2010-11-04

US20100279931A1

Human necessities

Insulin derivative

#33 | 2010-10-14

US20100261637A1

Chemistry; metallurgy

PEPTIDES DERIVATIZED WITH A-B-C-D- AND THEIR THERAPEUTICAL USE

#34 | 2010-09-09

US20100227796A1

Human necessities

Insulin Derivatives

#35 | 2010-08-26

US20100216715A1

Human necessities

FGF21 derivatives with albumin binder A-B-C-D-E- and their use

#36 | 2010-02-04

US20100028939A1

Chemistry; metallurgy

Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest

#37 | 2009-09-24

US20090239785A1

Chemistry; metallurgy

Insulin derivative

#38 | 2009-09-10

US20090227504A1

Human necessities

Pegylated factor VII glycoforms

#39 | 2009-05-28

US20090137454A1

Chemistry; metallurgy

Insulin derivatives

#40 | 2009-04-23

US20090105121A1

Chemistry; metallurgy

Insulin derivative

#41 | 2008-11-06

US20080275066A1

Chemistry; metallurgy

Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists

#42 | 2008-07-17

US20080171695A1

Human necessities

Insulin Derivatives

#43 | 2008-05-08

US20080108557A1

Chemistry; metallurgy

Modified Proteins

#44 | 2008-03-27

US20080076705A1

Human necessities

Insulin derivatives

#45 | 2008-02-14

US20080039373A1

Human necessities

Pegylated Factor VII Glycoforms

#46 | 2006-09-07

US20060198819A1

Chemistry; metallurgy

Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest

#47 | 2005-05-26

US20050113565A1

Human necessities

Pegylated factor VII glycoforms

InventorID:

115962 ⎘